Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin

Since the approval of sodium-glucose cotransporter 2 (SGLT2) inhibitors by the US Food and Drug Administration for type 2 diabetes, there have been several reports of euglycemic diabetic ketoacidosis in patients using this class of medication. We present a case of euglycemic diabetic ketoacidosis wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Pujara, Shreya, Ioachimescu, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446101/
https://www.ncbi.nlm.nih.gov/pubmed/28589154
http://dx.doi.org/10.1177/2324709617710040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446101/
https://www.ncbi.nlm.nih.gov/pubmed/28589154
http://dx.doi.org/10.1177/2324709617710040

Ejemplares similares